Safety results from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or withoutbevacizumab (B) in patients (pts) with gastric or type II/III oesophagogastric junction (OGJ)adenocarcinoma

A Okines; Ruth  Langely; LC Thompson; SP Stenning; L  Stevenson; S Falk; MT Seymour; FY Coxon; Gary Middleton; D Smith; L Evans; S Slater; JS  Water; D Ford; M Hall; Tim Iveson; Russell David Petty; C Plummer; W Alum; David Cunningham

Safety results from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or withoutbevacizumab (B) in patients (pts) with gastric or type II/III oesophagogastric junction (OGJ)adenocarcinoma

A Okines, Ruth Langely, LC Thompson, SP Stenning, L Stevenson, S Falk, MT Seymour, FY Coxon, Gary Middleton, D Smith, L Evans, S Slater, JS Water, D Ford, M Hall, Tim Iveson, Russell David Petty, C Plummer, W Alum, David Cunningham

Applied Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	4092
Journal	Journal of Clinical Oncology
Volume	29
Issue number	Suppl.
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Okines, A., Langely, R., Thompson, LC., Stenning, SP., Stevenson, L., Falk, S., Seymour, MT., Coxon, FY., Middleton, G., Smith, D., Evans, L., Slater, S., Water, JS., Ford, D., Hall, M., Iveson, T., Petty, R. D., Plummer, C., Alum, W., & Cunningham, D. (2011). Safety results from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or withoutbevacizumab (B) in patients (pts) with gastric or type II/III oesophagogastric junction (OGJ)adenocarcinoma. Journal of Clinical Oncology, 29(Suppl.), Article 4092.

Safety results from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or withoutbevacizumab (B) in patients (pts) with gastric or type II/III oesophagogastric junction (OGJ)adenocarcinoma. / Okines, A; Langely, Ruth ; Thompson, LC et al.
In: Journal of Clinical Oncology, Vol. 29, No. Suppl., 4092, 2011.

Research output: Contribution to journal › Article › peer-review

Okines, A, Langely, R, Thompson, LC, Stenning, SP, Stevenson, L, Falk, S, Seymour, MT, Coxon, FY, Middleton, G, Smith, D, Evans, L, Slater, S, Water, JS, Ford, D, Hall, M, Iveson, T, Petty, RD, Plummer, C, Alum, W & Cunningham, D 2011, 'Safety results from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or withoutbevacizumab (B) in patients (pts) with gastric or type II/III oesophagogastric junction (OGJ)adenocarcinoma', Journal of Clinical Oncology, vol. 29, no. Suppl., 4092.

@article{07c9ac406a754d46ae2430b63d79761e,

title = "Safety results from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or withoutbevacizumab (B) in patients (pts) with gastric or type II/III oesophagogastric junction (OGJ)adenocarcinoma",

author = "A Okines and Ruth Langely and LC Thompson and SP Stenning and L Stevenson and S Falk and MT Seymour and FY Coxon and Gary Middleton and D Smith and L Evans and S Slater and JS Water and D Ford and M Hall and Tim Iveson and Petty, {Russell David} and C Plummer and W Alum and David Cunningham",

year = "2011",

language = "English",

volume = "29",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "Suppl.",

}

TY - JOUR

T1 - Safety results from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or withoutbevacizumab (B) in patients (pts) with gastric or type II/III oesophagogastric junction (OGJ)adenocarcinoma

AU - Okines, A

AU - Langely, Ruth

AU - Thompson, LC

AU - Stenning, SP

AU - Stevenson, L

AU - Falk, S

AU - Seymour, MT

AU - Coxon, FY

AU - Middleton, Gary

AU - Smith, D

AU - Evans, L

AU - Slater, S

AU - Water, JS

AU - Ford, D

AU - Hall, M

AU - Iveson, Tim

AU - Petty, Russell David

AU - Plummer, C

AU - Alum, W

AU - Cunningham, David

PY - 2011

Y1 - 2011

M3 - Article

SN - 0732-183X

VL - 29

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - Suppl.

M1 - 4092

ER -